🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Docetaxel injection

Found 400 matching trials

De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA

PHASE2

This phase II trial examines the use of blood-based biomarkers is to help i...

Status

Recruiting

Location

Mayo Clinic in Arizona

Start Date

2023-02-21

Trial ID

NCT05541016

Treatments Being Tested

Biospecimen Collection Cisplatin Computed Tomography Diffusing Alpha-emitter Radiation Therapy Docetaxel Intensity-Modulated Proton Therapy Intensity-Modulated Radiation Therapy Magnetic Resonance Imaging Modified Barium Swallow Study Observation Activity Positron Emission Tomography Quality-of-Life Assessment Questionnaire

A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

PHASE2

Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...

Status

Terminated

Location

Highlands Oncology Group

Start Date

2014-07

Trial ID

NCT02117024

Treatments Being Tested

Viagenpumatucel-L Metronomic Cyclophosphamide Physician's Choice Regimen (Vinorelbine, Erlotinib, Gemcitabine, Paclitaxel, Docetaxel, Pemetrexed)

Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer

PHASE2

The purpose of this study is to evaluate the role of combination therapy wi...

Status

Terminated

Location

Baylor College of Medicine - Methodist Hospital

Start Date

2007-08

Trial ID

NCT00521274

Treatments Being Tested

MVA 5T4 Docetaxel

Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer

PHASE2

This multi-center, open-label, phase II randomized controlled trial is to e...

Status

Suspended

Location

Sun Yat-sen Memorial Hospital

Start Date

2016-09

Trial ID

NCT02897050

Treatments Being Tested

Docetaxel Capecitabine Cyclophosphamide (tablet)Fluorouracil Epirubicin Cyclophosphamide (injection)

Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy

PHASE2

This predictive, randomized, double-blind, multi-center trial is going to e...

Status

Unknown

Location

Department of Pulmonary Medical Oncology, Tianjin Medical University Cancer Hospital

Start Date

2012-08

Trial ID

NCT01660399

Treatments Being Tested

Boanmycin Docetaxel

Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery

PHASE2

This phase II trial studies how well chemotherapy before surgery and radiat...

Status

Active Not Recruiting

Location

University of Arizona Cancer Center-Orange Grove Campus

Start Date

2019-03-12

Trial ID

NCT03493425

Treatments Being Tested

Carboplatin Cisplatin Docetaxel Image Guided Radiation Therapy Intensity-Modulated Radiation Therapy Laboratory Biomarker Analysis Questionnaire Administration Therapeutic Conventional Surgery

Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer

PHASE2

This phase II trial studies how well docetaxel or abiraterone acetate work ...

Status

Terminated

Location

Huntsman Cancer Institute/University of Utah

Start Date

2019-02-08

Trial ID

NCT03827473

Treatments Being Tested

Abiraterone Acetate Antiandrogen Therapy Docetaxel Prednisone Quality-of-Life Assessment Questionnaire Administration

Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.

PHASE3

This is a randomized, double-blind, multicenter trial，parallel control desi...

Status

Completed

Location

Fudan University Cancer Hospital

Start Date

2020-11-23

Trial ID

NCT04629846

Treatments Being Tested

Trastuzumab QL1209 Pertuzumab Docetaxel surgery

Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)

PHASE2

Urothelial carcinoma (UC) is the ninth most common cancer type worldwide. W...

Status

Active Not Recruiting

Location

Highlands Oncology Group - Springdale /ID# 270290

Start Date

2025-01-20

Trial ID

NCT06632951

Treatments Being Tested

Livmoniplimab Budigalimab Docetaxel Paclitaxel Docetaxel Paclitaxel Gemcitabine

Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients

PHASE2

A multicenter, prospective, open, randomized cohort, non controlled phase I...

Status

Completed

Location

Jie Ge

Start Date

2023-04-11

Trial ID

NCT06009627

Treatments Being Tested

dalpiciclib、Exemestane、Gosserine Docetaxel for injection、Epirubicin hydrochloride for injection、Cyclophosphamide for injection

Previous Next